Page last updated: 2024-08-25

aceclofenac and almotriptan

aceclofenac has been researched along with almotriptan in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
De Klippel, N; Giurgea, S; Herroelen, L; Jacquy, J; Louis, P; Monseu, G; Schoenen, J; Vandenheede, M1
Burstein, R; Jakubowski, M1

Reviews

1 review(s) available for aceclofenac and almotriptan

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Trials

1 trial(s) available for aceclofenac and almotriptan

ArticleYear
Almotriptan and its combination with aceclofenac for migraine attacks: a study of efficacy and the influence of auto-evaluated brush allodynia.
    Cephalalgia : an international journal of headache, 2008, Volume: 28, Issue:10

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Drug Therapy, Combination; Female; Humans; Logistic Models; Male; Middle Aged; Migraine Disorders; Multivariate Analysis; Physical Stimulation; Pilot Projects; Prevalence; Serotonin Receptor Agonists; Somatosensory Disorders; Treatment Outcome; Tryptamines

2008

Other Studies

1 other study(ies) available for aceclofenac and almotriptan

ArticleYear
Almotriptan efficacy in migraine with allodynia: a critique of Schoenen et al.
    Cephalalgia : an international journal of headache, 2009, Volume: 29, Issue:10

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Drug Therapy, Combination; Female; Humans; Logistic Models; Male; Middle Aged; Migraine Disorders; Multivariate Analysis; Physical Stimulation; Pilot Projects; Prevalence; Serotonin Receptor Agonists; Somatosensory Disorders; Treatment Outcome; Tryptamines

2009